Skip to main content
Not yet activatedNot yet activated

Trout Roe

Trout Roe

Overview​

Trout roe comes from rainbow trout (Oncorhynchus mykiss) and related farmed lines. Like salmon roe, it delivers EPA, DHA, and phospholipid-associated fatty acids together with choline and vitamin B12 in a compact matrix. Mechanistic discussions of LPC-associated DHA transport apply to phospholipid-rich seafood matrices generally [1][2].

Within the BRAIN Diet framework, trout roe is best viewed as a mid-tier roe option: it is often less expensive per gram than premium salmon ikura, while still offering strong omega-3 and choline density compared with most land-animal foods. Exact fatty-acid and carotenoid profiles remain product-dependent; species-specific compositional tables should replace the current proxy when available.

Key Nutritional Highlights​

  • Phospholipid-context omega-3s (EPA/DHA) with very high choline per 100 g (proxy panel).
  • Vitamin B12 density is typically high in salmonid roe; values shift by product.
  • Usually more accessible pricing than top-grade salmon roe in many markets.
  • Farmed trout supply chains vary — quality and freshness still dominate practical value.
  • Compositional data here use a USDA mixed-roe proxy until a trout-roe FDC record is wired in.

Food Context​

Synergies​

  • Works well as a garnish on whole grains, vegetables, or mild fish to spread flavour without large sodium loads (unlike heavily salted caviar substitutes).

Sourcing​

  • Farmed trout roe is common; look for clear labelling, cold-chain handling, and use-by guidance.
  • Colour can range from orange to amber depending on pigment inputs — not a sole quality indicator.

Preparation​

  • Serve cold or lightly warmed like other roe; minimise heat and air exposure to protect unsaturated fats.

Essential Amino Acid Profile​

This food provides a complete essential amino acid profile typical of animal proteins.

Recipes​

no recipes found

Nutrition

Reliable composition data for this preparation are not yet available.

Recorded constituents

Bioactive compounds

Compound / classContentNotes
PhosphatidylcholinePresent [3]rainbow trout roe
Sources and limitations
  • Phosphatidylcholine: Reported in rainbow trout roe. [3]
Technical provenance
Source note 1

Phosphatidylcholine: Kaitaranta (1982), Hydrolytic changes in the lipids of roe products during storage. Primary abstract separately identifies the lecithin phospholipid fraction in rainbow trout roe, using lecithin as PC class, contrasted with cephalin. No PC fraction percentage converted to food mass. [3]

Substances​

5 substances in this food
Chemical structure

Choline

Contains choline bound in phosphatidylcholine; a separate total-choline amount is unavailable.

Source

References​

[1] Mechanistic discussions of LPC-associated DHA transport apply to phospholipid-rich seafood matrices generally. Patrick et al. 2019. Role of phosphatidylcholine-DHA and LPC-DHA in brain transport

[2] DHA supplied as phospholipid supports brain DHA accretion more effectively than DHA as triglyceride in neonatal models — supporting the biological relevance of roe's phospholipid-rich matrix. Liu et al. 2014. Higher efficacy of phospholipid omega-3 for brain DHA accretion (porcine model)

[3] Kaitaranta (1982), Hydrolytic changes in the lipids of roe products during storage

[4] Comparison of Chemical Composition and Safety Issues in Fish Roe Products (2020)

Food composition → admitted dietary relationships

These links join food composition to existing PM admissions. They do not establish that a portion reproduces an intervention, delivers an intact cofactor to tissue, or improves a clinical outcome. Derived supply retains its conversion and delivery limits.

  • Choline → BRS1-FM2-PM6 · Type A / direct
    Food form & relationship limits

    Choline is required and diet supplies it, but additional intake has not been shown here to raise acetylcholine synthesis in the human brain or improve attention.

    rainbow trout roe; form not known.

  • Phosphatidylcholine → BRS1-FM2-PM6 · Type A / derived
    Food form & relationship limits

    Human tracer evidence establishes phosphatidylcholine as a choline-provision route; it does not show delivery to cholinergic terminals or increased brain acetylcholine synthesis.

    rainbow trout roe; form not known.

  • DHA → BRS1-FM3-PM7 · Type A / direct
    Food form & relationship limits

    Diet can provide DHA for membrane incorporation. That does not establish an ADHD treatment effect or a human dosing rule from the porcine phospholipid comparison.

    commercial salmon, trout or lumpfish roe; form not known.

  • Choline → BRS1-FM5-PM12 · Type A / direct
    Food form & relationship limits

    This is membrane-precursor provision through the Kennedy route. Choline was not isolated in the gerbil spine experiment; no increased human synapse number or benefit from extra intake is established.

    rainbow trout roe; form not known.

  • Docosahexaenoic acid (DHA) → BRS1-FM5-PM12 · Type B / direct
    Food form & relationship limits

    This is a preclinical structural state response, not proof of an indispensable intake or verified new synapse counts. It does not establish human synapse growth, ordinary-food equivalence or cognitive benefit. Developmental mouse marker and visual-response evidence is additional, context-specific support; marker abundance is not an ultrastructurally verified contact count.

    commercial salmon, trout or lumpfish roe; form not known.

  • Choline → BRS2-FM1-PM2 · Type A / derived
    Food form & relationship limits

    Choline oxidation can supply betaine, but increasing choline intake has not been shown to increase tissue BHMT flux. Human evidence is an eight-man depletion pilot, with the challenge response in four clinically depleted participants; tissue BHMT flux was not measured. Rat donor rescue and specific inhibition support the chain. This does not establish ordinary-diet limitation, response in every tissue or benefit above adequacy. Folate’s indirect constraint on BHMT remains unresolved.

    rainbow trout roe; form not known.

  • Choline → BRS2-FM3-PM7 · Type A / direct
    Food form & relationship limits

    Plasma tracing does not measure absolute hepatic flux, intermediary SAM, ordinary-food equivalence or benefit.

    rainbow trout roe; form not known.

  • Phosphatidylcholine → BRS2-FM3-PM7 · Type A / derived
    Food form & relationship limits

    Plasma tracing does not measure absolute hepatic flux, intermediary SAM, ordinary-food equivalence or benefit.

    rainbow trout roe; form not known.

  • EPA → BRS3-FM3-PM8 · direct
    Food form & relationship limits

    Five days of 2.4 g a day in healthy adults raised some pro-resolving mediators, not every mediator, and not a disease-resolution outcome.

    commercial salmon, trout or lumpfish roe; form not known.

  • DHA → BRS3-FM3-PM8 · direct
    Food form & relationship limits

    Five days of 2.4 g a day in healthy adults raised some pro-resolving mediators, not every mediator, and not a disease-resolution outcome.

    commercial salmon, trout or lumpfish roe; form not known.

  • DHA (Docosahexaenoic Acid) → BRS6-FM4-PM8 · Type B / direct
    Food form & relationship limits

    The DHA-specific increase in circulating adiponectin was observed at a high supplemental dose of 2.7 g/day DHA for ten weeks. Whether customary dietary intakes produce a comparable response remains unknown. The enriched-canola-oil trial supplied about 3.5 g DHA per 3,000 kcal of the study diet. The lower-dose fish-oil trial used 1.1 g/day total marine omega-3 and did not isolate DHA’s effect. These circulating hormone results do not establish adipose secretion, receptor sensitivity, clinical benefit or an effective dose from food.

    commercial salmon, trout or lumpfish roe; form not known.

  • DHA (Docosahexaenoic Acid) → BRS-X(ECS-PM2) · Type A / direct
    Food form & relationship limits

    Labelled neural-cell precursor experiments support formation; controlled oral-oil studies support corresponding plasma ethanolamide availability. Plasma concentration is not neuronal synthesis flux or receptor engagement, and no ordinary-food effective dose or clinical benefit is established. Direct is relative to this biosynthetic operation, not direct food content of synaptamide.

    commercial salmon, trout or lumpfish roe; form not known.

  • EPA (Eicosapentaenoic Acid) → BRS-X(ECS-PM2) · Type A / direct
    Food form & relationship limits

    The oral EPA/DHA intervention evidence measures circulating corresponding ethanolamides, not neuronal synthesis rates or independent clinical mediation. Preserve active-arm, formulation and mixture limits. Direct refers to substrate provision to production; food EPA content is not food EPEA content or a quantified conversion yield.

    commercial salmon, trout or lumpfish roe; form not known.